Acyclovir suspension
NDC 72205-170, Acyclovir, suspension, from Novadoz Pharmaceuticals LLC.
- Product NDC
- 72205-170
- Status
- Listed
- Labeler
- Novadoz Pharmaceuticals LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217393
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72205-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACYCLOVIR200 mg/5mL
Pharmacologic classes
DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72205-170-72 | 72205017072 | 473 mL in 1 BOTTLE (72205-170-72) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3efa1e5e-5a14-4724-a2ca-25702f10faedNADAC price for package 72205017072
GET /v1/drugs/nadac/72205017072
Use it
Look up 72205-170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72205-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72205-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.